PIK3CA and ovarian carcinoma: The MAF of PIK3CA mutation in endometrial glands did neither correlate with endometrial status (proliferative phase, secretory phase, or atrophy) nor did it correlate with FIGO stage in ovarian cancer cases (data not shown).